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Introduction emerged  in  1978  as  a  highly  contagious  and  very 
serious  disease  in  dogs  [1].  But  CPV-2  underwent  Canine parvovirus (CPV) is the most significant 
evolutionary changes after its emergence in the late  viral  cause  of  acute  haemorrhagic  enteritis  and 
1970s and within few years CPV-2 has been globally  myocarditis in puppies over the age of 3-4 months [1]. 
replaced by the newer antigenic variants viz., CPV-2a  CPV presumably originated as a host range variant 
and CPV-2b [1, 4, 8]. At present, the variants of CPV  from feline panleukopenia virus (FLV) that adapted to 
are distributed worldwide and the original prototype 2  new canine host via wild carnivores like minks and 
no longer circulates in the dog population [9, 10, 11].   foxes [2]. A small, round non-enveloped virus was 
In 2000, a new variant of CPV which was named as  observed by electron microscopy in stool specimens 
CPV-2c was reported in Italy [12]. This new variant  and tissues in affected animals. Subsequently, a novel 
was  distinguishable  from  CPV  2a/2b  by  the  parvovirus was isolated in both canine and feline cell 
substitution of Glu in lieu of Asn/Asp at 426 residue of  cultures [3]. The Canine parvovirus 2 (CPV-2) belongs 
the VP2 capsid protein; therefore it was also referred to  to the family Parvoviridae with the genome of linear 
as  Glu-426  mutant  [12].  Additional  amino  acid  single  stranded  DNA  of  5.2  kb  in  size.  The  CPV 
difference was observed in both CPV-2a and CPV-2b at  genome has two open reading frames (ORF) of which 
position 297 (Ser to Ala) [10]. This mutation was first  the first ORF encodes one non structural protein (NS1) 
appeared in 1993 in German CPV isolates and was  and the second ORF encodes two capsid proteins (VP1 
designated as New CPV-2a/2b [10].  and  VP2)  which  are  translated  from  alternatively 
Molecular diagnostic techniques like PCR based  spliced mRNA [4]. VP2 gene mainly comprises the 
methods had been the most reliable techniques having  icosahedral capsid of CPV, and only a few amino acid 
high degree of sensitivity and specificity in detecting  substitutions  in  its  sequence  can  alter  relevant 
CPV from faecal samples [12]. Amplification of VP2  immunological characteristics of the virus [5, 6, 7].
gene  fragment  (capsid  protein)  using  primers  like  Canine parvovirus (CPV) caused by CPV-2 
H /H   and  subsequent  sequencing  of  the  PCR  for rev
products covering the informative amino acids would 
definitely help in detecting genetic variation which 
exists between CPV-2 and its variants [12].
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Abstract
Aim: The present study was conducted to isolate and characterize canine parvovirus circulating in Southern India by genetic 
analysis of VP2 capsid protein gene.
Materials and Methods: In this study, 128 samples were collected from nine different locations covering five Southern 
Indian states (Pondicherry, Tamil Nadu, Kerala, Andhra Pradesh and Karnataka) . Out of 128 samples, 69 samples were found 
to be positive by PCR assay. Out of 69 positive samples, 36  were randomly selected and processed for virus isolation. Twenty 
viruses could be isolated successfully and 18 randomly selected isolate were subjected to VP2 gene sequence analysis along 
with 6 random clinical samples. 
Result: Seventeen isolates and 5 clinical samples were characterized as New CPV-2a (CPV2a with 297-SerꇦAla). But one 
isolate and one clinical sample had amino acids variations which were characteristics of New CPV-2b. The phylogenetic 
analysis revealed that one of the field isolates was found to be phylogenetically closely related to New CPV-2b strains of India; 
rest other sequences was found to share ancestral origins with New CPV-2a reference strains of Japan, China, Thailand and India.  
Conclusion: The present study revealed that the predominant CPV strain circulating in Southern India is New CPV-2a. There 
is also enough indication of New CPV-2b strain from different states of Southern India.
Keywords: Canine parvovirus (CPV), crandell feline kidney (CRFK) cell line, molecular epidemiology, phylogenetic 
analysis, sequence analysis.
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Most commercial vaccines available in India contain  cell line monolayer. Virus isolation was carried out as 
CPV-2 strain whereas; only one CPV-2b based vaccine  per the procedure recommended by Hirayama [16]. 
is available [13]. Therefore, further epidemiological  The infected monolayers were harvested at the 4th day 
survey  and  molecular  characterization  of  CPV  of post infection (with or without CPE) by three cycles 
involving  samples  from  larger  geographical  area  of  alternative  freezing  and  thawing.  The  virus 
would be extremely helpful in formulating a suitable  supernatants were screened for the presence of virus by 
vaccination strategy. PCR using the same primer pair H  and H . for rev
Hence, a study was planned on molecular survey 
Sequencing and phylogenetic analysis: The amplified  and characterization of canine parvovirus in Southern  PCR products of 18 randomly selected cell culture  India using PCR and subsequent sequencing of the  isolates and six randomly selected clinical samples  PCR products covering a portion of VP2 gene (capsid  were gel extracted and custom sequenced with primer  protein). The  genetic  analysis  of  canine  parvovirus  pair  Hfor/Hrev  using  the  automated  sequencer,  strains in dog population of various states in Southern  Applied  Biosystem  3100.  The  specificity  of  the  India will reveal the predominant CPV strain/strains  sequences  obtained,  the  nucleotide  variations  and  responsible  for  causing  outbreaks  in  a  larger  amino acid variations with respect to the VP2 gene  geographical area.  sequence of canine parvovirus were determined using 
Materials and Methods BLAST  [Basic  Local  Alignment  Search  Tool] 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi)  [13].  The  Clinical samples: A total of 128 faecal samples/rectal 
nucleotide sequences of VP2 gene were aligned with  swabs were collected from the dogs suspected to be 
sequences of prototype CPV strains (M38246- FPV;  suffering  from  diarrhoea/enteritis  due  to  canine 
M38245-CPV-2; M24003-CPV-2a; M74849-CPV-2b;  parvovirus infection from nine different cities namely 
AY742953-New  CPV-2a;  AY742955-New  CPV-2b;  Puducherry  (Pondicherry),  Chennai,  Coimbatore 
FJ222821- CPV-2c) using ClustalW (www.ebi.ac.uk/ (Tamil Nadu), Hyderabad, Tirupati (Andhra Pradesh), 
clustalw) and analyzed for the nucleotide variation of  Bangalore  (Karnataka),  Thrissur,  Palakad  and 
VP2 gene at positions 3675, 3685, 3699, 3909 and  Trivandrum (Kerala) covering all the Southern Indian 
4064 with the corresponding amino acid residues at  states, India, during a period of 11 months from April 
297, 300, 305, 375 and 426, respectively [13]. 2011  to  February  2012  (Table-1).  The  collected 
For phylogenetic analysis, 30 canine parvovirus  samples were emulsified in 1 ml of 0.1 M PBS of pH 
o sequences  from  various  parts  of  the  world  were  7.4 and centrifuged at 6000 rpm for 15 min at 4 C. The 
retrieved from the GenBank and used. The sequences  supernatant  was  collected  and  used  for  PCR 
were aligned using ClustalW 1.8 program and .aln and  amplification and for virus isolation [13].
.nxs files were generated. The .aln file was converted to 
Template DNA preparation: Hundred microlitres of the  .meg file using Mega4.1 [17] and Neighbor Joining 
processed  supernatant  was  used  for  template  DNA  tree (NJ tree) was constructed (bootstrap replicates = 
o preparation by boiling at 96 C for 10 min and chilling  1000;  seed  =  64,248)  using  Kimura  2  parameter 
immediately in crushed ice [14]. The supernatants were  method for pairwise deletion at uniform rates [13]. 
diluted  1:10  in  distilled  water  to  reduce  residual  The CPV sequences of 18 cell culture isolates and 
inhibitors of DNA polymerase activity [15]. 6  clinical  samples  under  study  were  submitted  in 
GenBank  under  the  accession  numbers  JF900758,  Primer  pair  and  PCR  amplification:  The  processed 
JF900759,  JF900760,  JF900761,  JF900762,  samples  were  screened  by  primer  pair  H-for  (5' 
JN008380,  JN008381,  JN008382,  JN008383,  CAGGTGATGAAT TTGCTACA-3') and H-rev (5'-
JN008384,  JN008385,  JN008386,  JN008387,  CATTTGGATAAACTGGTGGT-3')  that  amplifies 
JN008388,  JN008389,  JN008390,  JN008391,  630 bp fragment of the gene encoding capsid protein. 
JN008392,  JN008393,  JN008394,  JN008395,  PCR amplification was carried out as per Buonavoglia 
JN008396,  JN008397 and JN008398 (Table-1). [12] and the products were analyzed by electrophoresis 
using 1.5% agarose gel in Tris acetate EDTA (TAE)  Results and Discussion
buffer (1X).  Out  of  128  samples  screened,  69  (53.90%)  Buonavoglia designed the primer pair H /H  and  for rev samples were found to be positive by PCR assay using 
utilized  them  for  sequencing  studies  of  canine  H primer. The disease was predominantly noticed in 
parvovirus since this primer pair amplifies a portion of  dogs between 0-6 months (73.91%) as also reported by 
VP2 gene containing the critical amino acids such as    other authors [13, 18, 19]. It was well known that 
297,  300,  305,  375  and  426,  which  helps  in  increased  intestinal  epithelial  turnover  caused  by 
characterization of canine parvovirus [12].  changes  in  the  microflora,  diet  (weaning)  and 
diminishing  maternal  antibody  level  were  the  Virus isolation: Thirty six processed clinical samples, 
predisposing factors to CPV infection in pups [20]. The  representing all the nine different locations which were 
occurrence of CPV enteritis, in this study, was found to  positive by PCR are randomly selected were filtered 
be more in males (62.31%) in comparison to females  using 0.22 mm membrane filter (Millipore) and the 
(37.68%).  High  percentage  of  occurrence  of  CPV  filtrates were used for virus isolation in 70-75% CRFK Available at www.veterinaryworld.org/Vol.6/Oct-2013/10.pdf
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infection  in  non-vaccinated  animals  (84.05%)  the maximum identity (95-99%) obtained with VP2 
indicated that current vaccines confer reasonably good  gene  sequence  of  other  canine  parvovirus  strains 
protection  [2,  21],  though  there  are  few  reports  of  available in the GenBank. 
vaccinated animals coming down with CPV infection  The partial VP2 gene of 24 sequences was aligned 
indicating vaccine failure [13, 19, 20] (Table-2). with the reference strains for sequence analysis. In 
Isolation of virus was attempted in CRFK cell line  comparison to prototype CPV-2 (CPV b, M38245), the 
from  36  samples  found  positive  by  PCR  assay  cell  culture  isolates  and  the  clinical  samples  under 
representing  the  diverse  locations  of  collection.  study had nucleotide variations at position 3675 (Tꇦ
Twenty samples showed mild cytopathic effects in the  G); 3685 (CꇦG); 3698 (GꇦT); 3908 (AꇦG) and 
form of rounding, increased granularity and detached  identical nucleotide (A) at position 4062 (Table 2). 
cells, from the third passage level onwards. Moderate  Seventeen  cell  culture  isolates  and  five  clinical 
isolation rate (55.55%) in this study may be attributable  samples had amino acids Ala, Gly, Tyr, Asp and Asn at 
to the presence of antibodies in the intestinal lumen of  residues  297,  300,  305,  375  and  426  respectively. 
the infected dogs, which may bind virions and prevent  These  nucleotide  variations  were  characteristics  of 
viral attachment to cell receptors. Similar observations  New CPV-2a (CPV-2a with nucleotide variation TꇦG 
were also made by Decaro and Mohanraj who observed  at position 3675 or CPV-2a with amino acid variation 
that the isolation of CPV could be done only for few  297-SerꇦAla).  In one cell culture isolate JN008393 
days of post infection [13, 14]. Cryolysates of all the  (Hyderabad)  and  one  clinical  sample  JF900762 
twenty samples were confirmed positive by PCR assay  (Palakkad) had amino acids Ala, Gly, Tyr, Asp and Asp 
using H /H  primer pair at the third passage level.  at residues 297, 300, 305, 375 and 426 respectively.  for rev
These  nucleotide  variations  were  characteristics  of  In  this  study,  the  amplified  PCR  products  of 
New CPV-2b (CPV-2b with nucleotide variation TꇦG  eighteen cell culture isolates and six clinical samples 
at position 3675 or CPV-2b with amino acid variation  were  gel  extracted  and  custom  sequenced  using 
297-SerꇦAla).  Automated Sequencer, Applied Biosciences 3100. The 
Twenty two out of 24 sequences had a nucleotide  sequences obtained were subjected to 'BLAST' to study 
variations which were characteristics of New CPV-2a,  specificity and strain identity.   Sequences obtained 
was also reported by other authors [10, 13, 15, 22]. This  were found to be highly specific to CPV as indicated by 
Table-1. Details of occurrence of CPV based on location (southern India)
State  Place No. of clinical  No. of samples positive Sequences submitted in Genbank
samples collected by PCR assay (H /H ) (Accession numbers) for rev
Pondicherry Pondicherry 25 11 JN008387, JN008388, JN008389
Tamil Nadu Chennai 20 12 JF900758, JN008383, JN008397
Coimbatore 10 8 JN008384, JN008396
Kerala Thrissur 10 4 JN008386
Palakkad 10 6 JF900762*, JN008385
Trivandrum 10 3 JN008392
Andhra Pradesh Hyderabad 10 7 JF900761, JN008393*, JN008398
Tirupati 15 9 JF900759, JN008390, JN008391
Karnataka Bangalore 18 9 JF900760, JN008380, JN008381, 
JN008382, JN008394, JN008395
Total 128 69(53.90%) 24 Sequence
*  Nucleotide  variations  were  characteristics  of  New  CPV-2b  (CPV-2b  with  amino  acid  variation  297Serꇦ Ala).  Other  Sequences  were 
characteristics of New CPV-2a (CPV-2a with amino acid variation 297 SerꇦAla)
Table-2. Details of occurrence of CPV based on age, sex and vaccination status
Status No. of samples collected  No. of samples positive by PCR assay
0-6 months  88  51 (73.91%) 
6-12 months  29  13 (18.84%) 
Above 12 months  11  5 (7.24%) 
Male  77  43 (62.31%) 
Female  51  26 (37.68%) 
Non-vaccinated  96  58 (84.05%) 
Vaccinated 32  11 (15.94%) 
Table-3. Nucleotides and amino acid variation in the VP2 protein of different CPV-2 
CPV Strains                                                        Nucleotides in CPV Genome
3676              3685             3699              3909               4062
Amino acid residue in VP2 297 300 305 375 426
CPV-2 TCT/Ser GCT/Ala GAT/Asp AAT/Asn AAT/Asn
CPV-2a TCT/Ser GGT/Gly TAT/Tyr GAT/Asp AAT/Asn
CPV-2b TCT/Ser GGT/Gly TAT/Tyr GAT/Asp GAT/Asp
New CPV-2a GCT/Ala GGT/Gly TAT/Tyr GAT/Asp AAT/Asn
New CPV-2b GCT/Ala GGT/Gly TAT/Tyr GAT/Asp GAT/Asp
CPV-2c GCT/Ala GGT/Gly TAT/Tyr GAT/Asp GAA/GluAvailable at www.veterinaryworld.org/Vol.6/Oct-2013/10.pdf
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is in accordance with the result reported by Chinchkar,  carnivores  [25].  The  residue  324  was  adjacent  to 
who also indicated that, CPV-2a was the predominant  residue 323, which affected canine transferrin receptor 
type in India [23]. They reported that out of twenty two  (TfR)  binding  and,  together  with  residue  93, 
CPV isolates from different parts of India, eighteen  determined the canine host range [25]. Therefore, the 
belonged to CPV-2a, remaining four belonged to CPV- 324  mutation  was  likely  to  have  an  effect  on  the 
2b  and  sixteen  of  the  twenty  two  isolates  had  parvovirus host range. This mutation resulted in the 
substitution 297-Serꇦ Ala. Nandi also reported the  codon change from TATꇦATT, indicating change in 
circulation of strain CPV-2a, CPV-2b and CPV-2c in  amino acid residue from TyrꇦIle. Other one was at 
the northern Indian geographical area [24]. Similarly,  nucleotide position 4104 (amino acid residue 440), 
two New CPV-2b strains were detected indicating the  where variation (AꇦG) was observed in case of all the 
presence of New CPV-2b also in certain locations of  sequences under study except JN008388, JN008389. 
Southern India. Alignment of the deduced amino acid  This  mutation  resulted  in  the  codon  change  from 
sequences of partial VP2 gene of the representative  ACAꇦGCA, revealing change in amino acid residue 
canine  parvovirus  field  isolate/sample  JN008391,  from  Thrꇦ Ala.  Similar  codon  change  (GCA)  at 
JN008395 (New CPV 2a), JN008393, JF900762 (New  nucleotide position 4104 was also reported in the CPV 
CPV-2b) and the reference strains is shown in Figure-1. isolated in Northern America by Kapil [26]. Therefore 
In addition to the nucleotide variations at positions  these two non-synonymous mutations indicated that 
3675, 3685, 3698, 3908 and 4062, two additional non- the CPV strains were under constant selection pressure 
synonymous mutations were observed in the canine  and were constantly evoluting which might lead to 
parvovirus  sequences  under  study.  At  nucleotide  evolution of newer CPV strains/variants in the future.
position  3756-3758  (amino  acid  residue  324),  In addition to non-synonymous mutations, three 
variations at 3756 (Tꇦ A) and 3757 (Aꇦ T) were  synonymous  mutations  were  also  observed  in  the 
observed  in  sequences  JN008387,  JF900758,  sequences under study. One was at nucleotide position 
JN008397,  JN008383,  JN008384,  JN008396,  3824 (amino acid residue 346), where variation (Gꇦ
JN008386, JF900762, JN008385 and JN008392. This  A)  was  observed  in  sequences  JN008388  and 
type of mutation was also reported in the CPV isolated  JN008389. This mutation resulted in the codon change 
in China by Zhang [14]. Horiuchi revealed that the  from GAGꇦGAA, both of them coded for Glutamic 
residue 324 was prone to strong positive selection in all  acid (Glu). Similar codon (GAA) change at nucleotide 
Figure-1. Alignment of the deduced amino acid sequences of partial VP2 gene. Sequence of the representative canine parvovirus field 
isolate/sample JN008391, JN008395 (New CPV 2a), JN008393, JF900762 (New CPV-2b) is shown aligned with the reference strains M38246 
(FPV), M38245 (CPV-2), M24003 (CPV-2a), M74849 (CPV-2b), AY742953 (New CPV-2a), AY742955 (New CPV-2b) and FJ222821 (CPV-2c) 
obtained from the GenBank.Available at www.veterinaryworld.org/Vol.6/Oct-2013/10.pdf
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(NewCPV-2a, Taiwan), CPU72696 (NewCPV-2b, Taiwan), EF599096  position 3824 was present in prototype FPV and was 
(NewCPV-2a, South Korea), EF599097 (NewCPV-2b, South Korea),  also reported in the CPV isolated in India by Chinchkar  GU380298 (NewCPV-2a, China), GU380299 (NewCPV-2b, China), 
GQ379044  (NewCPV-2a,  Thailand),  FJ869124  (NewCPV- and Mohanraj [13, 23]. Other one was at nucleotide 
2b,Thailand),  DQ025997  (NewCPV-2a,  France),  DQ025992  position  4074  (amino  acid  residue  430),  where  (NewCPV-2b, France).
variation (GꇦA) was seen in JN008380, JF900760,  Phylogenetic analysis of nucleotide sequences of  JN008381, and JN008382, was also reported in the  CPV obtained in this study with thirty reference CPV  CPV isolated in Japan by Doki [27]. This mutation  strains from various parts of the world using neighbor- resulted in the codon change from TTGꇦTTA, both of  joining method with Bootstrap consensus tree (Fig.-2)  them coded for Leucine (Leu).  Another one mutation  revealed that one of the field isolates JN008393 was  was  seen  at  nucleotide  position  4121  (amino  acid  found  to  be  phylogenetically  closely  related  (with 
residue 445), where variation (TꇦC) was observed in  bootstrap value of 80) to New CPV-2b strains of India. 
JN008388,  JN008389,  JN008390,  JN008391,  The  sequence  JN008394,  JN008398,  JN008395, 
JF900759,  JN008393,  JN900761,  JN008398,  JN008391 and JF900761 was closely related to New 
JN008380,  JF900760,  JN008381,  JN008394,  CPV-2a strain from Japan. The sequence JF900762, 
JN008395  and  JN008382.  This  particular  variation  JN008385,  JN008392,  JN008386,  JN008383, 
changed the codon from ACTꇦACC, both of which  JN008397,  JF900758,  JN008384,  JN008396  and 
coded for the same amino acid Threonine (Thr). This  JN008387 were clustered phylogenetically with New 
synonymous mutation was not observed in any of the  CPV-2a  from  China  and  Thailand  The  remaining 
previously isolated CPVs except in CPVs isolated from  sequence JN008390, JN008382 JN008381, JN008380 
India [13, 23].  All these mutations further confirmed  and JF900760 were phylogenetically related to New 
sustained constant evolution of canine parvovirus in  CPV-2a  strain  from  India.  Phylogenetic  analysis 
the  geographical  region  of  South  India.  Therefore,  revealed  that  one  of  the  isolates  was  found  to  be 
constant surveillance and monitoring involving larger  phylogenetically  closely  related  to  New  CPV-2b 
geographical areas are must to identify the nucleotide  strains of India and most of the sequences under this 
variations resulting in change in amino acids leading to  study were clustered together showing distinct lineage 
any possible antigenic variation between vaccine virus  but share ancestral origin with New CPV-2a reference 
and field strains. strains of Japan, China, Thailand and India.  
Conclusion
In this study, New CPV-2a (297-SerꇦAla) was 
found  to  be  the  predominant  strain  prevalent  in 
different  cities  across  five  Southern  Indian  states/ 
Union territories. There was also enough indication of 
circulation of New CPV-2b strain from different states 
of Southern India. As the CPV strains were found to be 
under immense selection pressure and realizing the 
constant  mutations  happening  in  the  field  strains, 
continuous  monitoring  and  detection  of  genetic 
variations  and  antigenic  changes  will  be  of  utmost 
importance to control CPV infections. As there were 
reports of occurrence of CPV in vaccinated pups under 
this study, cross antigenic evaluation of CPV vaccines 
and  field  strains  is  needed  for  evaluating  the  real 
efficacy of CPV vaccines available in the market. The 
major  share  of  CPV  positive  cases  in  this  study 
belonged to unvaccinated dog population, so there is a 
need  for  improving  public  awareness  about 
vaccination of pets against CPV infection. 
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